University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
College of Pharmacy

Darby Derringer, PharmD., BCTXP

Department

Pharmacy Practice, UAMS Medical Center Pharmacy

Education and Training

  • PharmD: University of Cincinnati James L. Winkle College of Pharmacy
  • PGY1: Indiana University Health, Indianapolis, IN
  • PGY2: Solid Organ Transplant, Indiana University Health, Indianapolis, IN

Teaching Responsibilities

  • PHPR 72045 – Introduction to Liver Disease
  • PHPR 72045 – Common Liver Diseases
  • PHPR 72045 – Complications of Cirrhosis
  • PHPR 72045 – Drug Induced Liver Injury
  • PHPR 72045 – Gastrointestinal Bleeding
  • APPE Preceptor
  • PGY1 Pharmacy Resident Preceptor

Clinical Practice

  • Manager of Clinical Pharmacy Services
  • Clinical Pharmacy Specialist in Solid Organ Transplant at UAMS Medical Center
  • PGY1 Pharmacy Residency Program Co-Coordinator

Research and Scholarly Interests

  • Immunosuppression, opportunistic infections

Honors and Awards

  • 2021 UAMS Medical Center Transplant Department Cherry Award
  • 2022 UAMS Medical Center Chancellor’s Circle Grant

Memberships

  • American Society of Transplantation (AST)

Publications

  • Harrington HP, White AH, Morgan EG, Wells AN, Derringer DA. Ideal Body Weight-Based Dosing of Rabbit Anti-Thymocyte Globulin in Obese Kidney
  • Transplant Recipients: Cutting Costs Without Adding Risk. Arch Phar & Phrmacol Res. 2024; 4(4).

 

Trey Gardner, PharmD.

Department

Pharmacy Practice

Education

  • Bachelor in Science – University of Central Arkansas
  • Doctorate of Pharmacy – University of Arkansas for Medical Sciences, College of Pharmacy

Research and Scholarly Interests

  • Managed Care Pharmacy
  • Evidence-Based Medicine
  • Pharmaceutical Industry
  • Clinical Trial Development

Honors and Awards

  • Arkansas Pharmacists Association Distinguished Young Pharmacist of the  Year, 2001

Memberships

  • AMCP
  • APhA
  • Arkansas Pharmacists Association
Curriculum Vitae

Ian McVinney, Pharm.D., BCOP

Department

Pharmacy Practice

Education and Training

  • 2023: PGY2 Oncology Residency, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences; Aurora, CO
  • 2022: PGY1 Residency, Baptist Memorial Hospital – Memphis; Memphis, TN
  • 2021: Doctor of Pharmacy, University of Arkansas for Medical Sciences; Little Rock, AR
  • 2017: Bachelor of Arts in Chemistry, Hendrix College; Conway, AR

Teaching Responsibilities

  • Acute Care APPE Preceptor
  • PGY1 Pharmacy Residency Preceptor

Clinical Practice

  • Multiple Myeloma/Bone Marrow Transplant Clinical Pharmacy Specialist at UAMS Medical Center

Honors and Awards

  • 2021: Jordin Scholar Award
  • 2020: Lester E. Hosto/SNPhA Award
  • 2018/2019: NPhA of Arkansas Endowed Scholarship

Memberships 

  • American Society of Health-System Pharmacists (ASHP)
  • Arkansas Association of Health-System Pharmacists (AAHP)
  • Hematology/Oncology Pharmacy Association (HOPA)

Curriculum Vitae

Alina Viteri, PharmD

Department

Pharmacy Practice

Education and Training

  • PGY2 Infectious Diseases Pharmacy Residency (2022-2023)
    HSHS St. John’s Hospital
    Springfield, IL
  • PGY1 Pharmacy Practice Residency (2021-2022)
    HSHS St. John’s Hospital
    Springfield, IL
  • Doctor of Pharmacy (May 2021)
    Southern Illinois University Edwardsville
    Edwardsville, IL

Clinical Practice

  • Infectious Diseases and Antimicrobial Stewardship
  • UAMS Medical Center

Memberships

  • Phi Lambda Sigma
  • Infectious Diseases Society of America (IDSA)
  • Society of Infectious Diseases Pharmacists (SIDP)

Curriculum Vitae

Amit K. Tiwari Ph.D., DABT

Pharmaceutical Sciences

Education and Training

  • Postdoc, Mount Sinai School of Medicine, NY, 2013
  • Ph.D., Pharmaceutical Sciences, St. John’s University, NY, 2011
  • M.S., Pharmaceutical Sciences, St. John’s University, NY, 2008
  • B.S., Pharmacy RamEesh Institute, U.P.T.U., India, 2005

Research and Scholarly Interests

  • Dr. Tiwari directs the Cancer and Systems Therapeutics (CAST) program at the University of Arkansas for Medical Sciences. CAST team is involved in a) developing effective, safe, and targeted anticancer therapeutics against multidrug-resistant cancers; b) designing, synthesizing and characterizing non-conventional forms of cell death inducers i.e. modulators of necroptosis, methuosis, and autophagy. CAST is also engaged in innovative drug delivery systems, natural products drug discovery, and chemical toxicity. CASTers are particularly interested in the identification of novel targets (single and multi-targets), synthesis and optimization of lead compounds, PK (ADME), PD (i.e. efficacy, model/assay developments, and mechanistic studies), drug-drug/herbal interactions, drug resistance, advanced toxicology assessments, and IP protection and commercialization.

Honors and Awards

SELECTED

  • Ambassador Award, Awarded by Govt. of Madhya Pradesh, India, in collaboration with MP Council of Science and Technology, 2023
  • President’s Award for Excellence in Creative and Scholarly Activity, University of Toledo, 2022
  • Outstanding Research and Scholarship Award, University of Toledo, 2022
  • Distinguished Young Alumni Award, St. John’s University, 2022
  • Outstanding Advisor Award, University of Toledo, 2021
  • Distinguished Scientist Award, International Association of Pharmacy Professionals, 2021

Memberships

  • American Association of Pharmaceutical Science
  • American Association of College of Pharmacy
  • American Cancer Society
  • Society of Toxicology
  • American Association for Cancer Research
  • American Society of Pharmacology and Experimental Therapeutics
  • American Association of University Professors
  • The Rho Chi Society
  • The Sigma Phi Sigma Society

Publications

Google Scholar

PUBMED

SELECTED PATENT APPLICATIONS

  • Raman D, Howard C, Nemunitis J, Brunicardi FC, Liu SH, and Tiwari AK. Targeting LASP1, elF4A1, e1F4B and CXCR4 with modulators And Combinations Thereof for Cancer Therapy (provisional D-2019-32, Ser. No. 62/807,075.) 2019
  • Tiwari AK, Hussein N, Ashby CR. Cariprazine and its analogues use in cancer therapy. (Application 60893-US-PSP/D2019-33, No. 62/934,638) 2019
  • Tiwari AK, Karthikeyan C, Nyinawabera, A. Necroptosis inducers and autophagy inhibitors in cancer therapy. (US patent application 2018, 60088-US-PSP/D2018-45).
  • Tiwari AK, Karthikeyan C, Amawi H, Erhardt P and Trivedi P. Materials and Methods Useful to Induce Cancer Cell Death Via Methuosis Or Autophagy Or A Combination Thereof. (US patent application 2017, 59593-US-PSP/D2018-15). Published 08-09-2022 – US11406626B2

Fathima Mubeeena Shaik

Fathima Mubeena Shaik is pursuing an MS in Bioinformatics.

Her research focus is the integration of multiomics data to examines the long term effects of Chemotheropatic Drugs like Cyclophosphamide, Methotrexate and Fluorouracil on Cognition.

Shaik: Resume

Justin Thomas

Justin Thomas has a Master of Science in Veterinary Biomedical Sciences form Lincoln Memorial University.

Jovan Grujicic

Jovan Grujicic graduated with honors from Ave Maria University with a BA in Biochemistry in 2021.

Jovan’s work focuses on understanding how tumor biology and cancer treatments can interact will provide novel insight about chemotherapy-induced cognitive impairment and may ultimately contribute to the development of strategies or approaches for the management of this serious complication

Bailey Cronin

Bailey Cronin graduated with honors from University of Arkansas – Little Rock with a BS in 2021.

Bailey’s research focus on the integration of multiple types of omics data to provides insights into the pathogenesis of chemobrain with hope of developing potential therapeutic targets.

Raymond Otoo

Raymond Otoo graduated with a Master of Science in Bioinformatics from the University of Texas El Paso.

Raymond’s work attempts to characterize the mechanisms by which characterize the mechanisms by which sulforaphane exerts its protective effect on the CNS and characterize the efficacy of SFN/Chemotherapy combination against a preclinical model of pediatric leukemia.